A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs
Clinical trial NCT06232564 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06232564
- Sponsor
- Imperial College London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2027-10-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.